Nuance Pharma Announces Strategic Licensing Deal with Antibe Therapeutics in China
Antibe Therapeutics Inc. announced that it has licensed otenaproxesul to Nuance Pharma for commercialization in the Greater China region. Nuance is a biopharmaceutical company focused…
Read More...
Read More...
